WellPoint’s net income has been down in both quarters so far this year, in addition to several quarters last year. Angela Braly, WellPoint’s chair, president and CEO, attributed the sluggish growth to lower enrollment figures and slightly higher medical costs, and WellPoint’s 2012 outlook has consequently been lowered.
Total revenue increased 2 percent in the second quarter, from $14.9 billion to $15.2 billion. For the six months ended June 30, WellPoint’s revenue equaled $30.3 billion — a 2.7 percent increase from $29.5 billion of revenue in the first six months of 2011.
WellPoint’s profit in the first six months of 2012 now stands at $1.5 billion, which is down 7.9 percent from $1.62 billion of profit last year.
More Articles on WellPoint:
WellPoint to Acquire Amerigroup for $4.9B
12 Major Healthcare Stock Winners, Losers From the PPACA Ruling
1Q Net Income at WellPoint Falls 7.6%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
